EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease

Ana Rita Agra Almeida Quadros, Zhaozhi Li, Xue Wang, I Sandra Ndayambaje, Sandeep Aryal, Nandini Ramesh, Matthew Nolan, Rojashree Jayakumar, Yi Han, Hannah Stillman, Corey Aguilar, Hayden J Wheeler und 18 weitere

Acta Neuropathologica · 2024-06 · 147 (1)

DOI: 10.1007/s00401-023-02655-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 04.01.2024. Verfasst von Ana Rita Agra Almeida Quadros und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Pick Disease of the Brain. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear clearance and cytoplasmic accumulations of the RNA-binding protein TDP-43 are pathological hallmarks in almost all patients with amyotrophic lateral sclerosis (ALS) and up to 50% of patients with frontotemporal dementia (FTD) and Alzheimer’s disease. In Alzheimer’s disease, TDP-43 pathology is predominantly observed in the limbic system and correlates with cognitive decline and reduced hippocampal volume. Disruption of nuclear TDP-43 function leads to abnormal RNA splicing and incorporation of erroneous cryptic exons in numerous transcripts including Stathmin-2 ( STMN2 , also known as SCG10 ) and UNC13A , recently reported in tissues from patients with ALS and FTD. Here, we identify both STMN2 and UNC13A cryptic exons in Alzheimer’s disease patients, that correlate with TDP-43 pathology burden, but not with amyloid-β or tau deposits. We also demonstrate that processing of the STMN2 pre-mRNA is more sensitive to TDP-43 loss of function than UNC13A . In addition, full-length RNAs encoding STMN2 and UNC13A are suppressed in large RNA-seq datasets generated from Alzheimer’s disease post-mortem brain tissue. Collectively, these results open exciting new avenues to use STMN2 and UNC13A as potential therapeutic targets in a broad range of neurodegenerative conditions with TDP-43 proteinopathy including Alzheimer’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyotrophic Lateral SclerosisFrontotemporal DementiaPick Disease of the BrainHumansDNA-Binding ProteinsRNA SplicingRNA, MessengerStathminNerve Tissue Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseCryptic exonsSCG-10Stathmin-2TARDBPTDP-43UNC13A

Substanzen

DNA-Binding ProteinsRNA, MessengerStathminTARDBP protein, humanUNC13B protein, humanNerve Tissue ProteinsSTMN2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Neurology, MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Broad Institute of Harvard University and MIT, Cambridge, MA, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
  • Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.

ORCID-Profile: Nilüfer Ertekin-Taner, Clotilde Lagier-Tourenne

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NCRR NIH HHS
  • NIGMS NIH HHS
  • BrightFocus Foundation
  • Friedrich Naumann Stiftung
  • Association for Frontotemporal Degeneration
  • ALS Association

Zitieren

APA

Agra Almeida Quadros, A. R., Li, Z., Wang, X., Ndayambaje, I. S., Aryal, S., Ramesh, N., Nolan, M., Jayakumar, R., Han, Y., Stillman, H., Aguilar, C., Wheeler, H. J., Connors, T., Lopez-Erauskin, J., Baughn, M. W., Melamed, Z., Beccari, M. S., Olmedo Martínez, L., Canori, M., …, & Lagier-Tourenne, C. (2024). Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-023-02655-0

Vancouver

Agra Almeida Quadros AR, Li Z, Wang X, Ndayambaje IS, Aryal S, Ramesh N, et al. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease. Acta Neuropathologica. 2024;147(1). doi:10.1007/s00401-023-02655-0

BibTeX
@article{AgraAlmeidaQuadros2024,
  author = {Agra Almeida Quadros, Ana Rita and Li, Zhaozhi and Wang, Xue and Ndayambaje, I Sandra and Aryal, Sandeep and Ramesh, Nandini and Nolan, Matthew and Jayakumar, Rojashree and Han, Yi and Stillman, Hannah and Aguilar, Corey and Wheeler, Hayden J and Connors, Theresa and Lopez-Erauskin, Jone and Baughn, Michael W and Melamed, Ze'ev and Beccari, Melinda S and Olmedo Martínez, Laura and Canori, Michael and Lee, Chao-Zong and Moran, Laura and Draper, Isabelle and Kopin, Alan S and Oakley, Derek H and Dickson, Dennis W and Cleveland, Don W and Hyman, Bradley T and Das, Sudeshna and Ertekin-Taner, Nilüfer and Lagier-Tourenne, Clotilde},
  title = {Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease},
  journal = {Acta Neuropathologica},
  year = {2024},
  volume = {147},
  number = {1},
  doi = {10.1007/s00401-023-02655-0}
}
Kostenlos starten →